198 related articles for article (PubMed ID: 18508515)
1. Osteopontin as a target for cancer therapy.
Johnston NI; Gunasekharan VK; Ravindranath A; O'Connell C; Johnston PG; El-Tanani MK
Front Biosci; 2008 May; 13():4361-72. PubMed ID: 18508515
[TBL] [Abstract][Full Text] [Related]
2. Role of osteopontin in cellular signaling and metastatic phenotype.
El-Tanani MK
Front Biosci; 2008 May; 13():4276-84. PubMed ID: 18508510
[TBL] [Abstract][Full Text] [Related]
3. The regulation and role of osteopontin in malignant transformation and cancer.
El-Tanani MK; Campbell FC; Kurisetty V; Jin D; McCann M; Rudland PS
Cytokine Growth Factor Rev; 2006 Dec; 17(6):463-74. PubMed ID: 17113338
[TBL] [Abstract][Full Text] [Related]
4. Role of the metastasis-promoting protein osteopontin in the tumour microenvironment.
Anborgh PH; Mutrie JC; Tuck AB; Chambers AF
J Cell Mol Med; 2010 Aug; 14(8):2037-44. PubMed ID: 20597997
[TBL] [Abstract][Full Text] [Related]
5. The role of Osteopontin in tumor metastasis.
Wai PY; Kuo PC
J Surg Res; 2004 Oct; 121(2):228-41. PubMed ID: 15501463
[TBL] [Abstract][Full Text] [Related]
6. Osteopontin Promotes Cell Migration and Invasion, and Inhibits Apoptosis and Autophagy in Colorectal Cancer by activating the p38 MAPK Signaling Pathway.
Huang RH; Quan YJ; Chen JH; Wang TF; Xu M; Ye M; Yuan H; Zhang CJ; Liu XJ; Min ZJ
Cell Physiol Biochem; 2017; 41(5):1851-1864. PubMed ID: 28376477
[TBL] [Abstract][Full Text] [Related]
7. Pathophysiological role of osteopontin in hepatic inflammation, toxicity, and cancer.
Ramaiah SK; Rittling S
Toxicol Sci; 2008 May; 103(1):4-13. PubMed ID: 17890765
[TBL] [Abstract][Full Text] [Related]
8. The RGD domain of human osteopontin promotes tumor growth and metastasis through activation of survival pathways.
Courter D; Cao H; Kwok S; Kong C; Banh A; Kuo P; Bouley DM; Vice C; Brustugun OT; Denko NC; Koong AC; Giaccia A; Le QT
PLoS One; 2010 Mar; 5(3):e9633. PubMed ID: 20224789
[TBL] [Abstract][Full Text] [Related]
9. [Advances in Research of Osteopontion and Its Receptor CD44v in Tumor Invasion and Metastasis].
Sun B; Zhang Z
Zhongguo Fei Ai Za Zhi; 2015 Nov; 18(11):714-7. PubMed ID: 26582229
[TBL] [Abstract][Full Text] [Related]
10. The functional and clinical roles of osteopontin in cancer and metastasis.
Furger KA; Menon RK; Tuck AB; Bramwell VH; Chambers AF
Curr Mol Med; 2001 Nov; 1(5):621-32. PubMed ID: 11899236
[TBL] [Abstract][Full Text] [Related]
11. Osteopontin regulates ubiquitin-dependent degradation of Stat1 in murine mammary epithelial tumor cells.
Gao C; Mi Z; Guo H; Kuo PC
Neoplasia; 2007 Sep; 9(9):699-706. PubMed ID: 17898865
[TBL] [Abstract][Full Text] [Related]
12. Distinctive Prognostic Value and Cellular Functions of Osteopontin Splice Variants in Human Gastric Cancer.
Hao C; Cui Y; Lane J; Jia S; Ji J; Jiang WG
Cells; 2021 Jul; 10(7):. PubMed ID: 34359989
[TBL] [Abstract][Full Text] [Related]
13. Control of osteopontin signaling and function by post-translational phosphorylation and protein folding.
Kazanecki CC; Uzwiak DJ; Denhardt DT
J Cell Biochem; 2007 Nov; 102(4):912-24. PubMed ID: 17910028
[TBL] [Abstract][Full Text] [Related]
14. Osteopontin: an emerging therapeutic target for anticancer therapy.
Jain S; Chakraborty G; Bulbule A; Kaur R; Kundu GC
Expert Opin Ther Targets; 2007 Jan; 11(1):81-90. PubMed ID: 17150036
[TBL] [Abstract][Full Text] [Related]
15. The role of osteopontin in the progression of solid organ tumour.
Zhao H; Chen Q; Alam A; Cui J; Suen KC; Soo AP; Eguchi S; Gu J; Ma D
Cell Death Dis; 2018 Mar; 9(3):356. PubMed ID: 29500465
[TBL] [Abstract][Full Text] [Related]
16. Agelastatin A: a novel inhibitor of osteopontin-mediated adhesion, invasion, and colony formation.
Mason CK; McFarlane S; Johnston PG; Crowe P; Erwin PJ; Domostoj MM; Campbell FC; Manaviazar S; Hale KJ; El-Tanani M
Mol Cancer Ther; 2008 Mar; 7(3):548-58. PubMed ID: 18347142
[TBL] [Abstract][Full Text] [Related]
17. The role of osteopontin expression in melanoma progression.
Kiss T; Ecsedi S; Vizkeleti L; Koroknai V; Emri G; Kovács N; Adany R; Balazs M
Tumour Biol; 2015 Sep; 36(10):7841-7. PubMed ID: 25944164
[TBL] [Abstract][Full Text] [Related]
18. Osteopontin and thrombospondin-1 play opposite roles in promoting tumor aggressiveness of primary resected non-small cell lung cancer.
Rouanne M; Adam J; Goubar A; Robin A; Ohana C; Louvet E; Cormier J; Mercier O; Dorfmüller P; Fattal S; de Montpreville VT; Lebret T; Dartevelle P; Fadel E; Besse B; Olaussen KA; Auclair C; Soria JC
BMC Cancer; 2016 Jul; 16():483. PubMed ID: 27422280
[TBL] [Abstract][Full Text] [Related]
19. Osteopontin as a therapeutic target for cancer.
Bandopadhyay M; Bulbule A; Butti R; Chakraborty G; Ghorpade P; Ghosh P; Gorain M; Kale S; Kumar D; Kumar S; Totakura KV; Roy G; Sharma P; Shetti D; Soundararajan G; Thorat D; Tomar D; Nalukurthi R; Raja R; Mishra R; Yadav AS; Kundu GC
Expert Opin Ther Targets; 2014 Aug; 18(8):883-95. PubMed ID: 24899149
[TBL] [Abstract][Full Text] [Related]
20. Elevated plasma osteopontin associated with gastric cancer development, invasion and survival.
Wu CY; Wu MS; Chiang EP; Wu CC; Chen YJ; Chen CJ; Chi NH; Chen GH; Lin JT
Gut; 2007 Jun; 56(6):782-9. PubMed ID: 17148500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
